Page last updated: 2024-11-06

n-(n-butyl) thiophosphoric triamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID93502
CHEMBL ID3186430
SCHEMBL ID180545
MeSH IDM0307136

Synonyms (37)

Synonym
94317-64-3
n-butylphosphorothioic triamide
n-diaminophosphinothioylbutan-1-amine
A844914
n-diaminophosphinothioylbutan-1-amine;n-(n-butyl)thiophosphorictriamide
n-(n-butyl)thiophosphoric triamide
dtxsid4044747 ,
dtxcid2024747
cas-94317-64-3
NCGC00256311-01
tox21_302015
AKOS006230585
a6103ok7gf ,
unii-a6103ok7gf
phosphorothioic triamide, butyl-
phosphorothioic triamide, n-butyl-
FT-0629302
agrotain
n-butylphosphorothioic triamide [mi]
SCHEMBL180545
mfcd00269941
Q-201452
n-butylthiophosphoric triamide
B5873
CHEMBL3186430
n-(n-butyl)thiophosphoric triamide, analytical standard
n-(n-butyl) thiophosphoric triamide
n-(n-butyl)thiophosphorictriamide
BCP05323
AS-15132
agrotain dc; agrotain plus; agrotain prime; agrotain ultra; armu; n-butylthiophosphoric triamide
Q27273672
n-(n-butyl)thiophosphoramide
HY-107199
CS-0027607
EN300-345781
butyl[diamino(sulfanylidene)-lambda5-phosphanyl]amine

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" However, there are few case studies about reduced N application combined with double inhibitors (DIs, NI plus UI), especially under drip irrigation systems."( A 2-year study of the impact of reduced nitrogen application combined with double inhibitors on soil nitrogen transformation and wheat productivity under drip irrigation.
Chu, G; Hu, B; Li, J; Shah, JA; Tao, R, 2021
)
0.62
"Cutting the N application rate by 20% combined with NBPT and nitrapyrin could provide a sustainable fertilization strategy for wheat production under drip irrigation."( A 2-year study of the impact of reduced nitrogen application combined with double inhibitors on soil nitrogen transformation and wheat productivity under drip irrigation.
Chu, G; Hu, B; Li, J; Shah, JA; Tao, R, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
"5% of initial BW and dosed with either 0 (control), ."( Influence of the novel urease inhibitor N-(n-butyl) thiophosphoric triamide on ruminant nitrogen metabolism: II. Ruminal nitrogen metabolism, diet digestibility, and nitrogen balance in lambs.
Axe, DE; Harmon, DL; Huntington, GB; Larson, BT; Ludden, PA, 2000
)
0.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency24.33650.000714.592883.7951AID1259392
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency13.68540.000657.913322,387.1992AID1259377
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency61.64480.000214.376460.0339AID720692
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency60.66600.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency61.39530.000229.305416,493.5996AID743075; AID743079
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency2.75360.057821.109761.2679AID1159526
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency30.63790.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.55)18.2507
2000's9 (40.91)29.6817
2010's10 (45.45)24.3611
2020's2 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.59 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]